Changes in Beneficial Ownership · 4
OptimizeRx Corporation
OPRXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1781113474.xml
Filing details
- Report period
- 2026-06-09
- Issuer
- OptimizeRx Corp
- Issuer CIK
- 0001448431
- Trading symbol
- OPRX
Reporting owner 1
- Name
- KLEMA CATHY
- Reporting owner CIK
- 0001181157
- Relationship
- Director
- Address
- C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM, MA, 02459
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-06-09 | A · Form 4 | 34,517[F1] | A | 0 | 56,137 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.↩ 1
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person fi ling this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the benefi cialowner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be fi led by such person.
Signature 1
- Signed
- /s/ Marion Odence-Ford, by Power of Attorney
- Date
- 2026-06-10
Company context
OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.